Are you Dr. Hennessy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Bryan Hennessy, MD is an oncologist in Houston, Texas. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2003 - 2004
University College of Dublin National Univ SOMClass of 1997
Clinical Trials
- A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer Start of enrollment: 2012 Feb 13
- A Translational Systems Medicine Approach to Provide Predictive Capacity for Therapy Response in Advanced or Metastatic Malignant Melanoma Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.Gavin P Dowling, Gordon R Daly, Aisling Hegarty, Michael Flanagan, Mihaela Ola
Cancer Communications. 2025-02-01 - Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.Charles E Geyer Jr, Michael Untch, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas
The New England Journal of Medicine. 2025-01-16 - Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models.Razia Aslam, Cathy E Richards, Joanna Fay, Lance Hudson, Julie Workman
International Journal of Molecular Sciences. 2024-12-10
Press Mentions
Better Testing Could Lead to Improved Treatments for a Specific Type of Ovarian CancerJune 8th, 2020
Irish Cancer Biotech Reaches a Vital Inflection PointSeptember 29th, 2017
